Bausch Health Companies Inc (TO:BHC) — Market Cap & Net Worth
Market Cap & Net Worth: Bausch Health Companies Inc (BHC)
Bausch Health Companies Inc (TO:BHC) has a market capitalization of $1.87 Billion (CA$2.59 Billion) as of June 17, 2026. Listed on the TO stock exchange, this Canada-based company holds position #6538 globally and #206 in its home market, demonstrating a -3.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bausch Health Companies Inc's stock price CA$6.93 by its total outstanding shares 373475644 (373.48 Million). Review Bausch Health Companies Inc total liabilities to assess the company's total debt and financial obligations.
Bausch Health Companies Inc Market Cap History: 2015 to 2026
Bausch Health Companies Inc's market capitalization history from 2015 to 2026. Data shows change from $37.97 Billion to $1.87 Billion (-27.47% CAGR).
Index Memberships
Bausch Health Companies Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P TSX Composite Index (Canada)
GSPTSE
|
$3.83 Trillion | 0.05% | #163 of 225 |
Weight: Bausch Health Companies Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bausch Health Companies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bausch Health Companies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
Bausch Health Companies Inc's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
16.12x
Bausch Health Companies Inc's market cap is 16.12 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.26 Billion | $9.67 Billion | -$2.41 Billion | 0.54x | N/A |
| 2017 | $7.08 Billion | $8.72 Billion | $2.40 Billion | 0.81x | 2.94x |
| 2018 | $6.82 Billion | $8.38 Billion | -$4.15 Billion | 0.81x | N/A |
| 2019 | $10.50 Billion | $8.60 Billion | -$1.78 Billion | 1.22x | N/A |
| 2020 | $7.14 Billion | $8.03 Billion | -$559.00 Million | 0.89x | N/A |
| 2021 | $9.44 Billion | $8.43 Billion | -$937.00 Million | 1.12x | N/A |
| 2022 | $2.30 Billion | $8.12 Billion | -$212.00 Million | 0.28x | N/A |
| 2023 | $2.87 Billion | $8.76 Billion | -$592.00 Million | 0.33x | N/A |
| 2024 | $3.14 Billion | $9.62 Billion | -$46.00 Million | 0.33x | N/A |
| 2025 | $2.57 Billion | $10.45 Billion | $159.75 Million | 0.25x | 16.12x |
Competitor Companies of BHC by Market Capitalization
Companies near Bausch Health Companies Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Bausch Health Companies Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Bausch Health Companies Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Bausch Health Companies Inc's market cap moved from $37.97 Billion to $ 1.87 Billion, with a yearly change of -27.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.87 Billion | -27.28% |
| 2025 | CA$2.57 Billion | -17.99% |
| 2024 | CA$3.14 Billion | +9.31% |
| 2023 | CA$2.87 Billion | +25.06% |
| 2022 | CA$2.30 Billion | -75.67% |
| 2021 | CA$9.44 Billion | +32.30% |
| 2020 | CA$7.14 Billion | -32.06% |
| 2019 | CA$10.50 Billion | +53.94% |
| 2018 | CA$6.82 Billion | -3.63% |
| 2017 | CA$7.08 Billion | +34.57% |
| 2016 | CA$5.26 Billion | -86.15% |
| 2015 | CA$37.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Bausch Health Companies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.87 Billion USD |
| MoneyControl | $1.87 Billion USD |
| MarketWatch | $1.87 Billion USD |
| marketcap.company | $1.87 Billion USD |
| Reuters | $1.87 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more